Angewandte Chemie International Edition
10.1002/anie.201905174
The methyl group at the α-carbonyl position in isomer B could
provide more steric influence to the 4-MeOPh coordination during
reductive elimination or transmetallation stage. The methyl group at
the α-carbonyl position in isomer B could provide more steric
influence to the 4-MeOPh coordination during reductive elimination
or transmetallation stage, and conformer A is likely to be favored,
leading to the coupling product with the observed stereochemistry.
obtained in 52% yield and 89% ee. Acidic treatment of 3r led to the
formation of (R)-flurbiprofen in 89% ee.
1
5
In conclusion, we have developed an enantioselective
palladium-catalyzed cross-coupling between α-bromo carboxamides
and arylboronic acids, leading to a wide series of chiral α-aryl
carboxamides in good yields and excellent enantioselectivities. The
nd
development of chiral P,P=O ligand is critical in overcoming the 2
Cl
Br
transmetallation issue and allows for the first time the asymmetric
Pd-catalyzed cross-coupling of α-bromo carbonyl substrate. The low
catalyst loading (as low as 0.5 mol %) of this asymmetric cross-
coupling protocol in contrast to other transition metal catalysis
makes it attractive for making anti-inflammatory drugs including
ibuprofen, naproxen, flurbiprofen. The concept of employing
sterically bulky phosphorus ligand with a secondary hemilabile
Cl
Br
NH2CH(2-MeOPh)2 (7)
NHR'
1
)
COOH
DCC, HOSu
O
7
2%
R' = CH(2-MeOPh)2
6
8
Pd(OAc)2 (1 mol %)
L11 (1.2 mol %)
Cl
CONHR'
1) CF3COOH, DCM
2) LiAlH4, THF
4
-MeOC6H4B(OH)2 (2a)
nd
coordination in inhibiting a 2 transmetallation as well as -hydride
OMe
K2CO3, toluene
7
5% (2 steps)
9
elimination should be applicable in developing a range of new
asymmetric transformations and research on this aspect is ongoing
in our laboratory.
5
1% yield, 90% ee
H
NH2
Cl
N
Ni(acac)2, SIPr
Received: ((will be filled in by the editorial staff))
Published online on ((will be filled in by the editorial staff))
NaOtBu, Dioxane
OMe 80% yield
OMe
10
11
Keywords:
transmetallation
aryl
ꞏ
alkyl
palladium
cross-couplingꞏ
ꞏ chiral phosphorus
2nd
2 N HCl, 80 o
C
O
COOH
2
)
ligands ꞏ flurbiprofen
References
NHR'
80%
R' = CH(2-MeOPh)2
[1] For reviews on enantioselective and enantiospecific aryl-alkyl
couplings: (a) A. H. Cherney, N. T. Kadunce, S. E. Reisman,
Chem. Rev. 2015, 115, 9587. (b) S. Z. Tasker, E. A. Standley,
T. F. Jamison, Nature. 2014, 509, 299.
[2] For transition-metal free cross-coupling, see: (a) C. Li, Y.
Zhang, Q. Sun, T. Gu, H. Peng, W. Tang, J. Am. Chem. Soc.
2016, 138, 10774. (b) D. Tian, C. Li, G. Gu, H. Peng, X. Zhang,
W. Tang, Angew. Chem., Int. Ed. 2018, 57, 7176; Angew.
Chem. 2018, 130, 7294.
3k
Ibuprofen (12)
9
0% ee
90% ee
O
3
)
N HCl, 80 o
COOH
2
C
NHR'
MeO
85%
MeO
R' = CH(2-MeOPh)2
Naproxen (13)
3% ee
3
y
9
9
4% ee
Br
[
3] (a) X. Dai, N. A. Strotman, G. C. Fu, J. Am. Chem. Soc. 2008,
130, 3302. (b) P. M. Lundin, J. Esquivias, G. C. Fu, Angew.
Chem., Int. Ed. 2008, 48, 154; Angew. Chem. 2008, 121, 160.
F
B(OH)2 Pd(OAc)2 (0.5 mol %)
NH
O
R'
+
L11 (0.6 mmol %)
KF, toluene, 70 oC
4
)
Ph
R' = CH(2-MeOPh)2
(c) P. M. Lundin, G. C. Fu, J. Am. Chem. Soc. 2010, 132,
2r
1e
11027. (d) S. Lou, G. C. Fu, J. Am. Chem. Soc. 2010, 132,
F
1264. (e) Q. M. Kainz, C. D. Matier, A. Bartoszewicz, S. L.
Zultanski, J. C. Peters, G. C. Fu, Science 2016, 351, 681. (f) Y.
Liang, G. C. Fu, J. Am. Chem. Soc. 2016, 136, 5520.
4] (a) J. Mao, F. Liu, M. Wang, L. Wu, B. Zheng, S. Liu, J. Zhong,
Q. Bian, P. J. Walsh, J. Am. Chem. Soc. 2014, 136, 17662. (b)
F. Liu, J. Zhong, Y. Zhou, Z. Gao, P. J. Walsh, W. Wang, S.
Ma, S. Hou, S. Liu, M. Wang, M. Wang, Q. Bian, Chem. Eur. J.
2018, 24, 2059.
F
COOH
CONHR'
2
N HCl, 80 o
C
8
2% yield
[
3r
(R)-Flurbiprofen (14)
5
2% yield, 89% ee
89% ee
Scheme 4. Synthetic applications (DCC = dicyclohexylcarbodiimide,
HOSu = N-hydroxysuccinimide, THF = tetrahydrofuran, acac =
acetylacetonate,
dihydroimidazol-2-ylidine)
SIPr
=
1,3-bis(2,6-diisopropylphenyl)-4,5-
[5] (a) M. Jin, L. Adak, M. Nakamura, J. Am. Chem. Soc. 2015,
137, 7128. (b) T. Iwamoto, C. Okuzono, L. Adak, M. Jin, M.
Nakamura, Chem. Commun. 2019, 55, 1128.
To demonstrate the synthetic utility of this asymmetric
transformation, the syntheses of several therapeutic agents were
studied. Thus, condensation between α-bromo carboxylic acid 6 and
[
6] C. Liu, C. He, W. Shi, M. Chen, A. Lei, Org. Lett. 2007, 9,
601.
5
[
7] (a) Q. Liu, Y. Lan, J. Liu, G. Li, Y.-D. Wu, A. Lei, J. Am.
Chem. Soc. 2009, 131, 10201. (b) A. Lei, X. Zhang,
Tetrahedron Lett. 2002, 43, 2525. (c) J. Wang, G. Meng, K.
Xie, L. Li, H. Sun, Z. Huang, ACS Catal. 2017, 7, 7421.
NH
provided amide 8 in 72% yield. Coupling of 8 with 2a in the
presence of Pd(OAc) (1 mol %) and L11 (1.2 mol %) led to the
formation of 9 in 51% yield and 90% ee. TFA treatment to remove
the N-CH(2-MeOPh) group followed by LiAlH reduction formed
the primary amine 10 in 75% overall yield over two steps.
2 2
CH(2-MeOPh) (7) under conditions of DCC and HOSu
2
[
8] For reviews on ligand development and cross-coupling: (a) G.
Xu, C. H. Senanayake, W. Tang, Acc. Chem. Res. 2019, 52,
2
4
1101. (b) H. Yang, W. Tang, Chem. Rec. 2019, DOI:
10.1002/tcr.201900003. (c) C. Li, D. Chen, W. Tang, Synlett.
2016, 27, 2183.
1
2
Intramolecular Ni-catalyzed C-N coupling formed 11, a CNS
1
3
agent
inflammatory drug ibuprofen (12) was formed in 80% yield from
k by acidic treatment with 2N HCl. Likewise, naproxen (13) was
in 80% yield. Meanwhile, the nonsteroidal anti-
1
4
[
[
9] (a) C. Li, T. Chen, B. Li, G. Xiao, W. Tang, Angew. Chem., Int.
Ed. 2015, 54, 3792; Angew. Chem. 2015, 127, 3863. (b) T. Si,
B. Li, W. Xiong, B. Xu, W. Tang, Org. Biomol. Chem. 2017,
3
obtained in 85% yield from 3y under similar reaction conditions. To
test the practicality of this asymmetric cross-coupling, reaction of 1e
and 2r was studied at a gram scale in the presence of Pd(OAc)
1
5, 9903.
2
(0.5
10] L. Chu, X.-C. Wang, C. E. Moore, A. L. Rheingold, J.-Q. Yu,
mol %) and L11 (0.6 mol %) and the desired product 3r was
J. Am. Chem. Soc. 2013, 135, 16344.
4
This article is protected by copyright. All rights reserved.